Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer

G Maric, AAN Rose, MG Annis… - OncoTargets and …, 2013 - Taylor & Francis
Molecularly targeted therapies are rapidly growing with respect to their clinical development
and impact on cancer treatment due to their highly selective anti-tumor action. However …

Targeting aging and age-related diseases with vaccines

R Wu, F Sun, W Zhang, J Ren, GH Liu - Nature Aging, 2024 - nature.com
Aging is a major risk factor for numerous chronic diseases. Vaccination offers a promising
strategy to combat these age-related diseases by targeting specific antigens and inducing …

Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility

G Solinas, S Schiarea, M Liguori, M Fabbri… - The Journal of …, 2010 - journals.aai.org
Tumor-associated macrophages (TAMs) are key orchestrators of the tumor
microenvironment directly affecting neoplastic cell growth, neoangiogenesis, and …

The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33

M Liguori, E Digifico, A Vacchini, R Avigni… - Cellular & molecular …, 2021 - nature.com
In cancer, myeloid cells have tumor-supporting roles. We reported that the protein GPNMB
(glycoprotein nonmetastatic B) was profoundly upregulated in macrophages interacting with …

Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia

M Hüttenrauch, I Ogorek, H Klafki, M Otto… - Acta neuropathologica …, 2018 - Springer
Alzheimer's disease (AD) is an irreversible, devastating neurodegenerative brain disorder
characterized by the loss of neurons and subsequent cognitive decline. Despite …

Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer

AAN Rose, AA Grosset, Z Dong, C Russo… - Clinical cancer …, 2010 - AACR
Purpose: Although the murine orthologue of glycoprotein nonmetastatic B (GPNMB),
Osteoactivin, promotes breast cancer metastasis in an in vivo mouse model, its importance …

Osteoactivin promotes breast cancer metastasis to bone

AAN Rose, F Pepin, C Russo, JE Abou Khalil… - Molecular Cancer …, 2007 - AACR
The skeleton is a preferred site of metastasis in patients with disseminated breast cancer.
We have used 4T1 mouse mammary carcinoma cells, which metastasize to bone from the …

The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis

H Tanaka, M Shimazawa, M Kimura, M Takata… - Scientific reports, 2012 - nature.com
Amyotrophic lateral sclerosis (ALS) is an incurable and fatal neurodegenerative disease
characterized by the loss of motor neurons. Despite substantial research, the causes of ALS …

Bone structure, development and bone biology

FF Safadi, MF Barbe, SM Abdelmagid, MC Rico… - Bone pathology, 2009 - Springer
The skeleton serves as an internal structural support system for vertebrates. It has
mechanisms to grow and change in shape and size to suit varying stressors including the …

Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function

SM Abdelmagid, MF Barbe, MC Rico… - Experimental cell …, 2008 - Elsevier
Osteoactivin (OA) is a novel glycoprotein that is highly expressed during osteoblast
differentiation. Using Western blot analysis, our data show that OA protein has two isoforms …